Pharm revision 2 Flashcards
two common features of GAs
loss of consciousness
suppression of reflex responses
Inhalation
NO
Diethyl ether
halothane
enflurane
IV GA
propofol
etomidate
GABAa units important in anaesthetics
Beta 3 = supression of reflex in IV
alpha 5 = amnesia in IV
alpha 1 = suppression of reflex inhalational
what other targets do inhalational GAs have
block NMDA type glutamate
neural nicotinic ACh receptors
TREK background leak potassium channels
2 parts of LA
aromatic and basic amine side chain
general characteristics of LA’s
do not influence resting membrane potential
selectively block small diameter and non-myelinated
weak bases
spinal vs epidural anaesthesia
spinal - sub arachnoid space
epidural = epidural space
lidocaine CNS effects
stimulation
restlessness
confusion
tremor
M1/M3 receptors are
Gq IP3 DAG linked
M2 receptors are
Gi cAMP linked
nAchR muscle vs ganglion
alpha alpha beta delta gamma
alpha x 2 beta x 3
pilocarpine and glaucoma
constriction of pupil leads to drainage via canals of schlemm
how do muscarinic agonists affect vasculature
vasc endothelial cells to make NO via M3
induces smooth muscle relaxation
what type of drug are bethanecol and pilocarpine
choline esters
alkaloids
pilocarpine and bethanecol side effects
blurred vision sweating GI pain hypotension resp distress bradycardia
cholinesterase inhibitors dosage effects
low dose = muscarinic inc
moderate = inc at all autonomic ganglia also
high = depolarising block at autonomic and NMJs
CNS effects of non polar anticholinesterases and eg
physostigmine
excitation but then unconsciousness, resp depression death
how to treat anticholinesterase poisioning when does it happen
organophosphate
atropine iv
pralidoxime iv
dual action of ganglion blocking drug and problem
ion channel and receptor blocker
use dependent
when is trimetaphan used
hypotension during surgery bc just blocks receptor
cns effects of atropine and hyoscine
mild restless and agitation
cns depression or paradoxical excitation
tropicamide moa and use
machr antag
mydriasis retina examination
machr antag and parkinsons
block M4 leads to dec inhibition of dopamine neurones
machr antag and asthma
ipratropium blocks bronchoconstriction
cant get into systemic bc ionised
side effects of first gen antipsychotics
EPS
chlorpromazine has anticholinergic more
clozapine
5ht2a antag resistant and negative neutropenia agrnaulocytosis myocarditis
quetiapine
H1 antag
less eps
aripiprazole
partial agonist d2 5ht1a
less side effects but no more efficacious
depression symptoms
misery low self esteem loss of motivation anhedonia slowing of thought and action loss of libido loss of appetite
unipolar depression reactive vs endogenous
stressful life event non familial
unrelated to external stress
familial
TCAs MOA
neuronal monoamine re-uptake inhibitors
also affect on alpha 2 , muscarinic, histamin, serotonin
antidepressants delayed effects
beta
5ht2a
TCA PK
highly PPB
hepatic metabolism into active metabolites
TCA unwanted
atropine like postural hypotension sedation due to h1 Acute toxicity = excitement delirum, coma resp depression CVS dysrhythmias and VF
TCA interactions
aspirin, phenytoin, warfarin
Hepatic = neuroleptics and oral contracepetives due to competition
potentiation of CNS
antihypertensive
MAOi eg
phenelzine
MAOi unwanted
atropine like but less than tca postural hypo sedation and seizures weight gain hepatotoxicity
MAOi interactions
tyramine
TCA = hypertensive
pethidine = hyperpyrexia, restlessness, coma, hypotension
Moclobemide
reversible MAO-A inhib with less drug interactions
SSRI interaction
TCA hepatic enzymes
interact with MAOis
SSRI unwanted
nausea diarrhoea insomnia loss of libido
Vanlafaxine
dose dependent reuptake inhib more ofr 5ht
2nd line for severe
SNRI
mirtazapine
alpha 2 antagonist
inc serotonin and na release
SSRI intolerant patients
thiopentone
barbiturate inducing anaesthetic
problems with barbiturates
low safety enzyme inducers potentiate cns depressants dependence tolerance
3rd bdz
oxazepam